ArticleVeterinary research communications2026
Evaluation of Toltrazuril and Sulfaclozine resistance in chicken coccidiosis in Vietnam and its impact on intestinal recovery.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study aimed to evaluate the drug resistance of Eimeria spp. in Vietnam to toltrazuril and sulfaclozine, and their effects on intestinal recovery. A total of 100 twelve-day-old chicks were randomly assigned to four groups: a negative control, a positive control, an Eimeria-infected group treated with toltrazuril, and an Eimeria-infected group treated with sulfaclozine. Treatments were administered from day 12 to day 21 of age. At day 14, all groups except NG were orally challenged with 2 × 10⁴ sporulated oocysts of Eimeria spp. The anticoccidial index, percentage of optimal anticoccidial activity, and reduction of lesion score, which reflect overall efficacy, performance, and intestinal damage, consistently indicated resistance for both toltrazuril and sulfaclozine, whereas reduction of oocyst production indicated sensitivity. However, based on an integrated assessment in which severe resistance is defined when resistance was detected in three or all four indexes, the Eimeria isolate was classified as exhibiting severe resistance to both drugs. Nevertheless, sulfaclozine treatment was associated with significantly improved body weight gain and reduced microscopic lesion scores. Given that oocyst output was comparable between the treated groups, these effects may not be directly attributable to inhibition of Eimeria development, but rather to host-related responses during intestinal recovery. The upregulation of Claudin family gene expression observed in the sulfaclozine-treated group may suggest a possible association with modulation of intestinal epithelial responses. This study emphasizes the importance of considering drug-resistance patterns when designing alternative strategies for coccidiosis control in poultry.
Indexed as
Identifiers
42171921What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.